Compounds > fanft
Page last updated: 2024-08-23

fanft and methotrexate

fanft has been researched along with methotrexate in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19906 (85.71)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blatnik, A; Brausi, M; Soloway, MS1
Niell, HB; Soloway, MS; Wood, CA1
Blatnik, AF; Brausi, M; Hickey, DP; Soloway, MS1
Soloway, MS1
Blatnik, A; Matheny, RB; Niell, HB; Soloway, MS1
Murphy, GP; Pontes, JE; Williams, PD1
Murphy, GP; Ochi, H; Pontes, JE; Sandberg, AA; Williams, PD; Yoshida, M1

Trials

1 trial(s) available for fanft and methotrexate

ArticleYear
Systemic therapy for superficial bladder cancer.
    Urology, 1984, Volume: 23, Issue:4 Suppl

    Topics: Animals; Antineoplastic Agents; Carcinoma in Situ; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; FANFT; Female; Fluorouracil; Humans; Male; Methotrexate; Mice; Neoplasm Recurrence, Local; Pyridoxine; Urinary Bladder Neoplasms; Vitamin A

1984

Other Studies

6 other study(ies) available for fanft and methotrexate

ArticleYear
Dose response relationship of methotrexate in combination with cisplatin in murine bladder cancer.
    Urology, 1990, Volume: 35, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Dose-Response Relationship, Drug; FANFT; Female; Leucovorin; Methotrexate; Mice; Mice, Inbred C3H; Urinary Bladder Neoplasms

1990
Effect of concentration and time of drug exposure on clonal growth of murine bladder cancer.
    Urology, 1985, Volume: 25, Issue:3

    Topics: Animals; Antineoplastic Agents; Bleomycin; Cell Line; Cisplatin; Colony-Forming Units Assay; Disease Models, Animal; Doxorubicin; FANFT; Female; Fluorouracil; Maytansine; Methotrexate; Mice; Mice, Inbred C3H; Mitomycin; Mitomycins; Podophyllotoxin; Streptozocin; Time Factors; Trichothecenes; Tumor Stem Cell Assay; Urinary Bladder Neoplasms

1985
Comparison of single agent cisplatin and cisplatin containing combinations in treatment of murine bladder cancer.
    Urology, 1987, Volume: 30, Issue:5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; FANFT; Female; Methotrexate; Mice; Mice, Inbred C3H; Mitomycin; Mitomycins; Urinary Bladder Neoplasms; Vinblastine

1987
Systemic chemotherapy of murine bladder cancer.
    Urology, 1984, Volume: 23, Issue:4 Suppl

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cell Line; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Etoposide; FANFT; Female; Methotrexate; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Urinary Bladder Neoplasms

1984
Evaluation of chemotherapy in a murine model for bladder cancer.
    Oncology, 1984, Volume: 41, Issue:3

    Topics: Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; FANFT; Lung Neoplasms; Male; Methotrexate; Mice; Mice, Inbred C3H; Organoplatinum Compounds; Time Factors; Urinary Bladder Neoplasms

1984
A murine model for bladder cancer.
    Progress in clinical and biological research, 1984, Volume: 162A

    Topics: Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Chromosomes; Cisplatin; Cyclophosphamide; DNA, Neoplasm; FANFT; Male; Methotrexate; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Organoplatinum Compounds; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms

1984